化工社
首页MCP工作台Skills
首页工作台通知我的
llms.txt · MCP 指南隐私政策 · 服务条款 · 支持v1.8.3
  1. 首页
  2. /反应

2-羟乙基吡嗪 → 2-哌嗪-2-乙醇

HRID 1075813
打印

反应方程式

HRID 1075813 反应方程式
[OH:1][CH2:2][CH2:3][C:4]1[CH:9]=[N:8][CH:7]=[CH:6][N:5]=1>CO.O=[Pt]=O>[OH:1][CH2:2][CH2:3][CH:4]1[CH2:9][NH:8][CH2:7][CH2:6][NH:5]1
参与物实验过程后处理来源与证据反应笔记

参与物

4

反应物 1

HCID 5222472-羟乙基吡嗪

产物 1

HCID 913082-哌嗪-2-乙醇

试剂、催化剂与溶剂 2

HCID 345198二氧化铂催化剂HCID 887Methanol溶剂

实验过程

A method for preparing each of the foregoing compounds is presented in the following examples. In general, however, the preparation is one wherein 2-(2-hydroxyethyl)-pyrazine (L. J. Kitchen and E. S. Hanson, Antibiot. Chemo., 73, 1838 (1951)) was reduced with H2 and PtO2 in MeOH to yield 2-(2-hydroxyethyl)piperazine (E. F. Rogers and H. J. Becker, U.S. Pat. No. 3,281,423 (1966)) which, in turn, was converted to the chloride. Ring closure in base afforded 1,4-diazabicyclo[ 3.2.1]octane which was acylated with ethylchloroformate to give 4-carbethoxy-1,4-diazabicyclo[ 3.2.1] octane or with diethylcarbamyl chloride to give 4-diethylcarbamyl-1,4-diazabicyclo[ 3.2.1] octane.

后处理

  1. customA method for preparing each of the foregoing compounds

来源与证据

ORD记录
ord-43e8a488a05449f293c4dedba1cb9c98
来源数据集
uspto-grants-1976_05
DOI
10.6084/m9.figshare.5104873.v1
专利号
US03954766

反应笔记

本页导航参与物实验过程后处理来源与证据反应笔记